A new trading day began on Tuesday, with Hoth Therapeutics Inc (NASDAQ: HOTH) stock price down -5.33% from the previous day of trading, before settling in for the closing price of $1.50. HOTH’s price has ranged from $0.58 to $3.80 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 44.78%. With a float of $6.84 million, this company’s outstanding shares have now reached $6.90 million.
Let’s determine the extent of company efficiency that accounts for 6 employees. In terms of profitability, gross margin is 50.0%, operating margin of -12647.51%, and the pretax margin is -12609.72%.
Hoth Therapeutics Inc (HOTH) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Hoth Therapeutics Inc is 0.93%, while institutional ownership is 5.31%. The most recent insider transaction that took place on Aug 16 ’24, was worth 16,750. In this transaction CEO and President of this company bought 25,000 shares at a rate of $0.67, taking the stock ownership to the 58,131 shares.
Hoth Therapeutics Inc (HOTH) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.25 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 44.78% per share during the next fiscal year.
Hoth Therapeutics Inc (NASDAQ: HOTH) Trading Performance Indicators
Here are Hoth Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 10.16.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.40, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -0.63 in one year’s time.
Technical Analysis of Hoth Therapeutics Inc (HOTH)
Looking closely at Hoth Therapeutics Inc (NASDAQ: HOTH), its last 5-days average volume was 1.57 million, which is a drop from its year-to-date volume of 41.99 million. As of the previous 9 days, the stock’s Stochastic %D was 19.09%. Additionally, its Average True Range was 0.33.
During the past 100 days, Hoth Therapeutics Inc’s (HOTH) raw stochastic average was set at 24.43%, which indicates a significant increase from 22.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 445.35% in the past 14 days, which was higher than the 202.74% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9875, while its 200-day Moving Average is $0.9682. However, in the short run, Hoth Therapeutics Inc’s stock first resistance to watch stands at $1.5267. Second resistance stands at $1.6333. The third major resistance level sits at $1.7167. If the price goes on to break the first support level at $1.3367, it is likely to go to the next support level at $1.2533. Now, if the price goes above the second support level, the third support stands at $1.1467.
Hoth Therapeutics Inc (NASDAQ: HOTH) Key Stats
With a market capitalization of 9.80 million, the company has a total of 6,904K Shares Outstanding. Currently, annual sales are 0 K while annual income is -7,850 K. The company’s previous quarter sales were 0 K while its latest quarter income was -2,130 K.
